BioMarin Pharmaceutical Inc. buy BMO Capital Markets
Start price
05.07.23
/
50%
€80.26
Target price
05.07.24
€93.60
Performance (%)
-6.16%
End price
06.07.24
€75.32
Summary
This prediction ended on 06.07.24 with a price of €75.32. With a performance of -6.16%, the BUY prediction for BioMarin Pharmaceutical Inc. by BMO_Capital_Markets closed slightly in the red. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 3.081% | 3.081% | -20.575% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by BMO_Capital_Markets for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $102.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten